My Account

Thursday, December 12, 2024

Canada’s Politics and Government News Source Since 1989

Patient involvement in pharmacare is critical to its success

Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.

Opinion
BY LOUISE BINDER AND FILOMENA SERVIDIO-ITALIANO
April 29, 2024

Opinion | BY LOUISE BINDER AND FILOMENA SERVIDIO-ITALIANO | April 29, 2024

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

Equity must be the priority for national pharmacare

OpinionBY CATHY AMMENDOLEA

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

An expanded pharmacare framework offers a lifeline for millions of people in Canada. It is time for federal, provincial, and territorial governments to deliver it.

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

An expanded pharmacare framework offers a lifeline for millions of people in Canada. It is time for federal, provincial, and territorial governments to deliver it.

Equity must be the priority for national pharmacare

OpinionBY CATHY AMMENDOLEA

Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.

Equity must be the priority for national pharmacare

OpinionBY CATHY AMMENDOLEA

Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.

Patient involvement in pharmacare is critical to its success

Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.

Why growing our own food has never been more critical

Elder Care in Canada: The Urgent Need for Improved Education and Training

Trump lights a proverbial fire north of the border

A new dawn: reflections on the end of the Syrian war

The consequential immigration minister

The great American brain drain: is Canada ready?

Global health is threatened with RFK Jr. at the helm of the U.S. file

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Equity must be the priority for national pharmacare

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

Multi-payer pharmacare will fail Canadians

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Equity must be the priority for national pharmacare

Equity must be the priority for national pharmacare

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

Multi-payer pharmacare will fail Canadians

Multi-payer pharmacare will fail Canadians

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

subscribe

get help

Get free news updates

Submit a guest opinion article

Patient involvement in pharmacare is critical to its success

Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.

Get The Policy Briefings Newsletter